Greene Street Pharmaceuticals
Pharmaceuticals, 3805 Old Easton Rd, Doylestown, Pennsylvania, 18902, United States, 1-10 Employees
Phone Number: 26********
Who is GREENE STREET PHARMACEUTICALS
We are experts in formulating and developing of transdermal pharmaceutical products. By offering a combination of development and direct manufacture, Greene Street is well positioned to b...
Read More
-
Headquarters: 3805 Old Easton Rd, Doylestown, Pennsylvania, 18902, United States
-
Date Founded: 2015
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
Does something look wrong? Fix it. | View contact records from GREENE STREET PHARMACEUTICALS
Greene Street Pharmaceuticals Org Chart and Mapping
Email
Phone
Similar Companies to Greene Street Pharmaceuticals
Baruch S. Blumberg Institute
-
11-50
-
$ 10 Million to 25 Million
NegotiumBio, LLC & GmbH
-
1-10
-
$ Under 1 Million
Pennsylvania Biotechnology Center
-
51-200
-
$ 5 Million to 10 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Greene Street Pharmaceuticals
Answer: Greene Street Pharmaceuticals's headquarters are located at 3805 Old Easton Rd, Doylestown, Pennsylvania, 18902, United States
Answer: Greene Street Pharmaceuticals's phone number is 26********
Answer: Greene Street Pharmaceuticals's official website is https://greenestreetpharma.com
Answer: Greene Street Pharmaceuticals's revenue is Under $1 Million
Answer: Greene Street Pharmaceuticals has 1-10 employees
Answer: Greene Street Pharmaceuticals is in Pharmaceuticals
Answer: Greene Street Pharmaceuticals top competitors include: Baruch S. Blumberg Institute , NegotiumBio, LLC & GmbH , Pennsylvania Biotechnology Center
Answer: Greene Street Pharmaceuticals contact info: Phone number: 26******** Website: https://greenestreetpharma.com
Answer: We are experts in formulating and developing of transdermal pharmaceutical products. By offering a combination of development and direct manufacture, Greene Street is well positioned to benefit the lives of patients and physicians. With Transdermal Innovative Products (TiPs) currently scheduled for animal studies and human clinical trials, Greene Street is able to unleash it's sizable pipeline for license. Our Transdermal Innovative Products match comparative oral drug specifications and efficacy, adhere to current FDA rules and guidelines, alleviate the majority of GI side effects encountered in oral drugs, and help improve delivery for patients with swallowing difficulties.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month